...
首页> 外文期刊>The Journal of Experomental Medicine >Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC-incompatible splenocytes veto clonal responses of antigen-reactive Lyt-2+ T cells.
【24h】

Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC-incompatible splenocytes veto clonal responses of antigen-reactive Lyt-2+ T cells.

机译:在成年小鼠中诱导对I类主要组织相容性复合物(MHC)同种抗原的外周耐受:输注的I类MHC不相容脾细胞对抗原反应性Lyt-2 + T细胞的否决克隆反应。

获取原文
           

摘要

The efficacy and the mode of action of pretransplant transfusion with class I major histocompatibility complex (MHC)-disparate splenocytes in establishing a state of peripheral tolerance in adult mice is analyzed. Adult mice injected intravenously with a critical number of approximately 5 x 10(7) allogenic splenocytes accept skin grafts and develop chimerism in the peripheral lymphatic tissues, but not in thymus and bone marrow. In parallel, a split tolerance evolves: the frequency of class I MHC-reactive Lyt-2+ cytotoxic T lymphocyte precursor (CTL-p)- and interleukin 2 (IL-2)-producing T cells falls off in the peripheral lymphoid tissue, but remains unaltered intrathymically. In particular, high affinity CTL-p become clonally undetectable. In vivo generation of tolerant cells is cyclosporin A resistant, but dependent on recipient L3T4+ T cells. Loss of Lyt-2+ CTL-p- and IL-2-producing T cell precursors is not due to active suppression, but is caused by clonal anergy. Donor-derived chimeric cells positively selected 7 d after intravenous transfusion exhibit in vitro the hallmarks of veto cells, i.e., paralyze CTL-p reactive to donor-type class I MHC alloantigens. We conclude that the peripheral (split) tolerance induced in vivo by pretransplant transfusion operates because donor-type cells develop in vivo efficiently into "veto cells," which in turn induce a state of clonal anergy within antigen-reactive Lyt-2+ T lymphocytes.
机译:分析了在成年小鼠中建立I类主要组织相容性复合体(MHC)不同的脾细胞的移植前输注的功效和作用方式。静脉注射约5 x 10(7)个同种异体脾脏关键数目的成年小鼠接受皮肤移植,并在外周淋巴组织而非胸腺和骨髓中产生嵌合现象。同时,产生了不同的耐受性:外周血淋巴组织中产生I类MHC反应的Lyt-2 +细胞毒性T淋巴细胞前体(CTL-p)-和产生白介素2(IL-2)的T细胞的频率降低,但胸腺内保持不变。特别地,高亲和力CTL-p变得克隆检测不到。体内耐受细胞的产生对环孢菌素A具有抗性,但取决于受体L3T4 + T细胞。产生Lyt-2 + CTL-p-和IL-2的T细胞前体的丢失不是由于主动抑制,而是由克隆无能引起的。静脉内输注后7天阳性选择的供体来源的嵌合细胞在体外表现出否决细胞的标志,即使对供体类型I类MHC同种抗原具有反应性的CTL-p瘫痪。我们得出的结论是,移植前输血在体内诱导的外周(分裂)耐受性起作用,因为供体型细胞在体内有效地发展为“否决细胞”,进而在抗原反应性Lyt-2 + T淋巴细胞内诱导了克隆无能状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号